🐋 USAR $1.4M Bullish Rare-Earth Bet — Whale Loads the Dec $30 Calls

📅 May 22, 2026 | 🔥 Unusual Activity Detected

---

🎯 The Quick Take

Someone just put $1.4 MILLION on the line betting USAR rallies above $30 by December — all in a single block of 2,000 contracts placed at 10:14 AM. With Vol/OI at ≈2.5x (fresh open interest, not a close), this is a new directional bet, not a hedge. The rare-earth theme is red-hot right now: China's export controls are still biting, USAR just commissioned its first domestic magnet line, and a $1.6B U.S. government funding package is still working its way to a definitive agreement. Translation: Someone's positioning for USAR to deliver on a loaded six-month catalyst calendar before these calls expire on December 18.

---

📊 Company Overview

USA Rare Earth (USAR) is a domestic "mine-to-magnet" rare-earth and critical-minerals company building a fully integrated U.S. supply chain — from the Round Top heavy-rare-earth deposit in West Texas, through metal/alloy processing, all the way to sintered NdFeB permanent magnets manufactured at its Stillwater, Oklahoma facility. Magnets like these go into EV motors, defense systems, industrial robotics, and semiconductors.

• Market Cap: ≈$5.8B (NASDAQ: USAR)
• Industry: Critical minerals / rare-earth magnets
• Current Price: $26.11 (spot at trade time); trading ≈$25.89 by mid-afternoon May 22
• 52-Week Range: $8.00 – $43.98
• YTD Performance: +114% — a policy-driven, high-beta rocket ship
• Revenue (Q1 2026): $5.7M — this is still a very early-stage commercial ramp

Important context: USAR is a small-cap, pre-revenue-scale company with a $5.8B market cap resting almost entirely on policy tailwinds, government backing, and execution promises. The valuation is a bet on what the company will become, not what it earns today.

---

💰 The Option Flow Breakdown

The Tape (May 22, 2026 @ 10:14:27):

🤓 What This Actually Means

This is a fresh bullish opening bet — a Buy to Open (BTO) on out-of-the-money calls:

• 💸 Premium paid: $1.4M ($6.95 per contract × 2,000 contracts, the reported block size)
• 🎯 Strike distance: $30 strike vs. $26.11 spot = ≈15% out-of-the-money. USAR needs to rally ≈15% just to reach the strike, and more than that to profit
• 📊 Fresh open interest: Volume (2,500) vs. prior OI (983) gives a Vol/OI ratio of ≈2.5 — this is overwhelmingly new open interest, not someone closing an existing position
• ⏰ Time horizon: Expiration December 18, 2026 — a 7-month window that spans the entire near-term catalyst calendar (first commercial shipments, CHIPS definitive agreement, Serra Verde/TMRC closings, Stillwater ramp, Q3 earnings, and the China comprehensive-restriction deadline landing in November 2026)
• 💰 Option price note: At $6.95 on a $30 call with spot $26.11, implied volatility is elevated — consistent with a small-cap, beta-2.41 name where the market is pricing real two-way risk

Real talk: This isn't a trillion-dollar hedge fund move — $1.4M is a meaningful but not enormous position. What makes it unusual is the conviction: a single 2,000-contract block, ≈15% OTM, seven months out, timed right as several major catalysts are pending. Whoever bought this is saying: "I think USAR's story plays out by December."

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

USAR has had a wild ride. The stock surged from the $8 area to an all-time high of $43.98 on the initial wave of government-funding headlines, pulled back sharply as the market absorbed dilution risk and the "LOI is not cash" reality, and has since stabilized in the mid-$20s — still up +114% YTD.

Key observations:

• 🚀 Massive YTD gain, but well off the highs: The stock is ≈41% off its $43.98 peak — a lot of the euphoria has already been unwound
• 📉 Recent volatility: Shares dropped May 21 to a $22.56 intraday low, then bounced +6.6% to $25.89 on May 22 — this is a name that moves hard on macro sentiment
• 🎢 Beta 2.41: Expect 2x the swing of the broader market on any given day. Strong-stomach territory
• 📊 Support building: The $22–$24 range appears to be a developing base after the post-highs flush

Gamma-Based Support & Resistance Analysis

With spot at ≈$25.63 at the time of the GEX snapshot, the gamma landscape reveals two tightly packed key levels right around the current price:

🔵 Support Level (Put Gamma Below Price):

• $25.00 — Strongest nearby support with total GEX of 8.30 (call GEX 5.50 + put GEX 2.80). This is the largest concentration of gamma in the entire near-money chain. Market makers are heavily positioned here, and a dip to $25 is likely to attract buying interest. This is the floor to watch.

🟠 Resistance Level (Call Gamma Above Price):

• $26.00 — Primary nearby resistance with total GEX of 6.69 (nearly evenly split between call and put gamma at 3.40 / 3.30). The near-neutral net GEX at $26 means the level won't act as a strong magnet in either direction — it's more of a minor speed bump than a wall. A clean break above $26 opens up the path toward $27 and $28.

Broader gamma context from the full strike chain:

• $27.00 — Secondary resistance with total GEX 2.14, mostly call-driven (call GEX 1.69) — meaningful but not a wall
• $28.00 — Call-dominant GEX of 1.43 vs 0.08 put; a real resistance zone the bulls need to clear to confirm upside momentum
• $30.00 — The whale's strike! Total GEX 2.86, nearly all call GEX (2.70). This is where the Dec $30 calls live — the market is pricing real open interest here, but the stock needs a full run to get there
• $20.00 and $21.00 — Deep put-gamma floors far below current price (GEX 2.81 and 2.40 respectively), indicating where the heaviest downside protection is clustered if the stock really breaks

Net GEX bias: Predominantly bullish/call-skewed above $22, consistent with the overall positioning in out-of-the-money calls across the chain.

What this means for the whale trade: The $30 strike sits ≈17% above spot and has genuine open interest behind it. It is not a random out-of-nowhere number — there is real gamma at that strike. But to get from $26 to $30, the stock must first clear the $26 speed bump, then push through the $27–$28 call-gamma wall, and then rally an additional ≈7% above $28 to reach $30. That is a lot of stacked resistance for a seven-month window — possible with the right catalysts, but not a layup.

Implied Move Analysis

Note: The implied move JSON for USAR reflects limited options market data across standard OPEX dates, which is common for small-cap names with thinner options liquidity. The option price of $6.95 on the Dec 18 $30 call (≈15% OTM) with spot at $26.11 implies annualized IV in the range of 60–80%, which is elevated but consistent with USAR's realized volatility profile (beta 2.41, 52-week range $8–$44).

What the option pricing tells us:

• 💸 Premium is expensive: Paying $6.95 for a ≈15%-OTM call means the market is pricing in very large potential moves in both directions. This is the cost of playing a high-octane small-cap theme
• 🎢 High IV = high hurdle: For the Dec $30 calls to break even, USAR needs to trade above approximately $36.95 at expiration ($30 strike + $6.95 premium paid). That is a ≈42% rally from today's $26.11 spot — a high bar, even with the catalyst stack
• ⚠️ Theta decay is real: Over seven months, time value erodes steadily. If the catalysts take time to materialize, the calls will lose value even if the stock treads water
• 📅 December expiry is strategically placed: It captures Q2 earnings (≈mid-August), Q3 earnings (≈November), the China comprehensive-restriction deadline (November 2026), Serra Verde/TMRC closing votes (Q3), Stillwater ramp milestones (Q4), and any CHIPS definitive-agreement news — a dense six-month window for potential catalysts

---

🎪 Catalysts

🔥 Immediate / Active Catalysts (Now Through Q2 2026)

First commercial magnet shipments — Q2 2026 (this quarter): USAR commissioned Phase 1a of its Stillwater, Oklahoma sintered-NdFeB magnet production line on March 26, 2026. First commercial shipments to paying customers are planned for Q2 2026 — the current quarter. This is the most important near-term operational proof point: can USAR actually ship product and generate revenue from its core magnet business?

CHIPS definitive-agreement signing — expected May 2026: Management stated on the Q1 2026 earnings call that it expects to sign a definitive agreement converting the $1.6B CHIPS LOI into binding documentation in May 2026. This is expected but not yet confirmed — it remains a non-binding LOI subject to diligence and approvals. Conversion would be a major sentiment catalyst.

China rare-earth export controls still biting: China's Ministry of Commerce defended its export restrictions as lawful after the May 2026 Trump-Xi summit, and benchmark mineral analysts confirm controls show little sign of easing. U.S. yttrium-oxide imports from China collapsed from 60 metric tons in March to just 10 metric tons in April — concrete evidence of supply stress that sustains the domestic-production urgency narrative. This is the macro wind at USAR's back right now.

📅 Near-Term Catalysts (Q3 2026 — within the option window)

Serra Verde ≈$2.8B acquisition close — expected Q3 2026: USAR signed a definitive agreement on April 20, 2026 to acquire Brazil's Serra Verde — the only at-scale non-Asian supplier of all four key magnetic rare earths — for $300M cash + 126.849M newly-issued USAR shares (≈$2.8B total). Serra Verde comes with a 15-year, 100% offtake agreement with price floors, providing demand de-risking. A USAR shareholder vote is the primary remaining condition. Close expected Q3 2026.

Texas Mineral Resources (Round Top) close — expected Q3 2026: The all-stock TMRC acquisition (≈$73M, 3.82M USAR shares) consolidates 100% control of the Round Top deposit, making USAR the sole economic beneficiary. Close expected by Q3 2026 pending shareholder approval.

Q2 2026 earnings — estimated mid-August 2026: The first earnings report after commercial magnet shipments begin. Key metrics to watch: actual shipment revenue (first real magnet sales), Stillwater run-rate progress toward the 600 MTPA target, CHIPS agreement status, and update on Serra Verde/TMRC votes. No formal company-confirmed date yet; mid-August is the working estimate based on USAR's historical cadence.

$14.2M Texas Semiconductor Innovation Fund grant (received May 2026): A state-level grant supporting the Round Top project — smaller in scale but another confirmed government backing data point.

🕐 Longer-Term Catalysts (Q4 2026 — approaching option expiry)

China comprehensive-restriction deadline — November 2026: A broader package of Chinese rare-earth restrictions was deferred to November 2026. This macro deadline lands right in the option's final month and could re-accelerate urgency for domestic-supply investors — or, if China softens, deflate the scarcity premium entirely. CSIS analysts flag China's restrictions as a direct threat to U.S. defense supply chains, sustaining bipartisan policy support.

Stillwater Phase 1a ramp to 600 MTPA — targeted Q4 2026: The capacity milestone target falls within the option window; Phase 1b (1,200 MTPA total) targeted for Q1 2027.

Q3 2026 earnings — estimated November 2026: Just around the Dec 18 expiry — the last major financial print before expiration.

✅ Past Catalysts (Already Happened — Set the Stage)

• Jan 26, 2026: $1.6B CHIPS LOI + ≈10% U.S. government equity stake announced; $1.5B PIPE closed concurrently — fueled the run to near $44
• Mar 26, 2026: Stillwater Phase 1a magnet line commissioned — operational de-risking milestone achieved
• May 13, 2026: Q1 2026 earnings beat ($5.7M revenue vs $4.3M consensus; adj. EPS −$0.12 beat) — stock dipped despite the beat, absorbing the large GAAP loss ($66.9M)
• May 14, 2026: Cantor Fitzgerald raised price target to $35 from $30, Overweight, more than doubling 2026/2027 revenue estimates

---

🎲 Price Targets & Probabilities

Using gamma levels, the option pricing math, and the catalyst calendar through December 18:

📈 Bull Case (20% probability)

Target: $35–$42 by Dec 18, 2026

How we get there:

• ✅ CHIPS definitive agreement signs in May/June, converting the $1.6B LOI to binding funding — removes a major overhang
• 🏭 First commercial magnet shipments in Q2 deliver real revenue and customer validation
• 🌏 China holds the line on export controls through November, escalating the supply-crisis narrative
• 🇧🇷 Serra Verde closes cleanly in Q3, making USAR a global mine-to-magnet platform
• 📊 Q2 and Q3 earnings show sequential revenue ramp — Cantor's $80.8M 2026 estimate starts looking credible
• 🚀 Stock re-tests the $35–$43 range that it visited earlier this year

Call P&L in Bull Case:

• USAR at $37 at expiry: Calls worth $7.00 (in-the-money by $7), breakeven covered with ≈$0.05 gain — essentially a scratch
• USAR at $40 at expiry: Calls worth $10.00, profit ≈$3.05 per contract × 2,000 = ≈$610K gain (≈44% ROI)
• USAR at $43 at expiry: Calls worth $13.00, profit ≈$6.05 per contract × 2,000 = ≈$1.21M gain (≈87% ROI)

Probability assessment: 20% — requires multiple high-uncertainty catalysts to land cleanly. The stock has been here before ($43.98) but was pricing in maximum optimism. Getting back there needs execution, not just hope.

🎯 Base Case (45% probability)

Target: $26–$34 range (choppy, below breakeven)

Most likely scenario:

• ⚖️ Catalysts materialize partially but with delays or complications: CHIPS agreement drags into summer, Serra Verde vote passes narrowly, first shipments are modest
• 📊 Stock grinds in the $24–$32 range — positive direction but not enough to push through the $30 strike cleanly
• 💤 Dilution pressure (Serra Verde's 126.85M new shares + the May share registration) caps upside on any rally
• 🎢 Macro volatility creates multiple gut-punch dips that test holder conviction
• 📉 Calls expire worthless or with minimal value — the whale loses most or all of the $1.4M premium

Why 45%: USAR's story is real, but the step from "story" to "stock above $30" requires catalysts to beat expectations AND the market to look past substantial dilution. The base case for a policy-driven small-cap is that good news gets priced in slowly and dilution is a persistent headwind.

📉 Bear Case (35% probability)

Target: $15–$25 (calls expire worthless, whale loses entire premium)

What could go wrong:

• 😰 CHIPS definitive agreement falls through, gets restructured at worse terms, or faces political challenge — Democratic lawmakers already raised questions about the government equity structure
• 🤝 U.S.-China rare-earth détente: China eases controls before November 2026, deflating the scarcity-premium thesis entirely
• 🇧🇷 Serra Verde close slips, shareholder vote fails, or Brazilian regulatory issues emerge — removes the key demand de-risking
• 📊 Commercial magnet shipments disappoint (thin margins, slow customer qualifications, execution hiccups)
• 🔴 Macro risk-off event crushes beta-2.41 names broadly
• 💸 The massive dilution from Serra Verde (≈34% share count increase) and the fresh May 2026 share registration overwhelm buyers even on positive news

Support levels to watch:

• 🛡️ $25.00 — Largest gamma floor in the near-money chain (total GEX 8.30) — this is where market makers will defend aggressively
• 🛡️ $20.00–$21.00 — Deep put-gamma cluster; a test of these levels would signal the thesis is under serious stress
• 🛡️ $15–$18 range — Pre-policy-premium territory; would require a full thesis unwind to reach

Call P&L in Bear Case:

• USAR at $25 or below at expiry: Calls expire worthless — loss = full $1.4M (100% of premium)
• USAR at $28 at expiry: Calls expire worthless — loss = full $1.4M (100%)
• USAR at $32 at expiry: Calls worth $2.00, loss = $4.95/contract × 2,000 = ≈$990K (71% loss)

Probability assessment: 35% — this is a high-beta, pre-revenue-scale company. The downside scenarios (policy reversal, deal failure, dilution overhang) are real and material.

---

💡 Trading Ideas

🛡️ Conservative: Watch and Wait — Let the First Shipment Confirm

Play: Stay on the sidelines until Q2 2026 commercial magnet shipment data is publicly confirmed

Why this works:

• 📊 The most important near-term binary event — actual revenue from the first magnet shipment — should be resolved within weeks. No need to front-run it
• 💸 At $6.95 per contract, options are expensive (high IV). Waiting for a catalyst to materialize (or disappoint) may give a better entry at lower IV
• ⚠️ The share registration and Serra Verde dilution are a real ceiling on near-term upside — cheaper to wait for the stock to absorb supply before buying options
• 🎯 If first shipments confirm real commercial traction, options should re-price higher on fundamentals, not just narrative

Action plan:

• 👀 Monitor for official Q2 2026 shipment announcement or pre-announcement — this should come before August earnings
• 🎯 If confirmed with real revenue, Dec $28 or $30 calls post-announcement could offer better risk/reward at lower IV
• ❌ Avoid initiating new calls while CHIPS agreement is still in LOI stage and Serra Verde vote has not yet been confirmed

Risk level: Minimal (cash) | Skill level: Beginner-friendly

⚖️ Balanced: Smaller Position in the Whale's Calls, with a Clear Stop

Play: Buy a smaller position in the Dec 2026 $30 calls (the same strike as the whale), sizing to risk 1–2% of portfolio maximum

Structure: Buy USAR Dec 2026 $30 calls

Why this could work:

• 🎯 You're aligned with the whale's thesis and strike — same expiry, same directional bet
• 📅 Seven months is enough time for the CHIPS definitive agreement, Serra Verde close, and first magnet shipments to all land
• 🌏 China export controls remaining in force through November 2026 is a genuine macro tailwind
• 📊 Analyst consensus is "Strong Buy" with a $37.43 average 12-month target — about 45% above current levels

Critical rules for this trade:

• ⚠️ Define your maximum loss upfront: These are OTM options that can expire worthless. Only risk money you are truly prepared to lose entirely
• 🎯 Breakeven is ≈$36.95 at expiry — a 42% rally from $26.11. That is a HIGH bar
• ⏰ Cut the position if CHIPS agreement falls through or Serra Verde vote fails — those are thesis-killers that would justify an early exit even at a loss
• 💡 Consider selling half the position if USAR hits $32–$34 mid-summer (lock in partial gains if the story is playing out)

Estimated P&L (rough, based on $6.95 entry):

• 📈 USAR at $35 at expiry: Calls worth ≈$5.00 — partial loss (30% loss of premium)
• 🚀 USAR at $40 at expiry: Calls worth ≈$10.00 — ≈44% gain on premium
• 📉 USAR at $28 or below at expiry: Calls expire worthless — 100% loss

Position sizing: No more than 1–2% of total portfolio in premium paid. This is speculative.

Risk level: Moderate | Skill level: Intermediate

🚀 Aggressive: Bull Call Spread — Reduce Premium Cost, Cap the Upside

Play: Buy the Dec $28/$35 call spread to reduce the capital at risk vs. buying naked calls

Structure: Buy USAR Dec $28 calls + Sell USAR Dec $35 calls (same expiry)

Why this could work:

• 💸 Cheaper than naked calls: Selling the $35 call finances part of the $28 call cost — the net debit is less than buying a standalone OTM call
• 🎯 The $28–$35 range captures the analyst consensus target zone and the gamma resistance band; you don't need the stock to run all the way to $40+
• 📊 Maximum profit on the spread if USAR closes above $35 at expiry — still a ≈34% rally, but a more realistic outcome than $42+
• 🛡️ Defined maximum loss = net debit paid for the spread

Important caveats:

• ⚠️ Selling the $35 call caps your upside — if USAR somehow rockets back to $44, you don't benefit above $35
• 🎢 Spreads on small-cap names can have wide bid-ask spreads; check liquidity before trading
• ⏰ Need to monitor and potentially close early if one leg becomes very ITM while the other stays OTM

Risk level: High (speculative spread, can lose full debit) | Skill level: Intermediate to Advanced

---

⚠️ Risk Factors

Do not sleepwalk into this trade. These are real risks that could wipe the position:

• 💸 Premium is expensive, breakeven is far: The whale paid $6.95 per contract. That means USAR needs to be above $36.95 at December expiry for the trade to break even — a 42% rally from today's $26.11. Even a legitimately bullish outcome where USAR rises to $32–$34 still results in a loss on the calls. High IV cuts both ways: the market is pricing in huge uncertainty, not a guaranteed rally.

• 🔀 CHIPS agreement is still a non-binding LOI: The $1.6B government package is a Letter of Intent subject to diligence, final agreements, and approvals. Democratic lawmakers have raised questions about the government equity structure. An LOI is not a check — if terms change materially or the definitive agreement gets delayed beyond the option window, this is a major downside catalyst.

• 📉 Heavy dilution is a structural ceiling: The Serra Verde deal adds 126.85 million new shares (≈34% of current outstanding) and a May 2026 share registration filed 32.51M new shares and 94.36M holder shares. That is a LOT of stock supply absorbing buying pressure. Even positive news can get muted when the market knows a large secondary offering is coming.

• 🧮 Tiny revenue for a $5.8B market cap: Q1 2026 revenue was $5.7M with a $67M GAAP net loss and 1.9% gross margin. Even Cantor's optimistic 2026 estimate of $80.8M implies a ≈72x revenue multiple at current market cap. This is a story stock, and story stocks are fragile when sentiment turns.

• 🌏 Policy reversal risk: The entire thesis rests partly on China maintaining export controls. After the May 2026 Trump-Xi summit, China said it would address U.S. concerns on "reasonable" grounds. A surprise détente or partial easing before November 2026 could deflate the domestic-supply scarcity premium quickly.

• 🇧🇷 Serra Verde deal complexity: Cross-border acquisition of a Brazilian producer — requires USAR shareholder vote, Brazilian regulatory approvals, and only ≈9% of votes are pre-committed. A failed or delayed vote means no Serra Verde offtake deal, no demand de-risking, and a material re-rating of the story.

• 🎢 Beta 2.41 + macro sensitivity: USAR fell to $22.56 intraday on May 21 purely on a broad market selloff — no company-specific news. At beta 2.41, a 5% market selloff can mean a 10–12% drop in USAR. Over seven months, that kind of volatility can shake out holders and drain time value from calls even if the thesis is intact.

• ⏳ Theta is working against option holders every day: Options lose value as time passes, all else equal. Seven months sounds like a long time, but if the major catalysts (CHIPS, Serra Verde vote) get delayed to Q4, much of the time value will have eroded by then.

---

🎯 The Bottom Line

Real talk: This is a high-conviction, high-risk bet on a rare-earth theme with a loaded catalyst calendar. The whale spent $1.4M on ≈15%-OTM December calls that need a 42% rally just to break even — that is not a timid trade. It is a bet that USAR's six-month catalyst stack (first shipments, CHIPS definitive agreement, Serra Verde close, Stillwater ramp, China restriction deadline) is real and will push the stock back toward the $35–$44 range it visited earlier this year.

What this trade tells us:

• 🎯 The buyer thinks at least one of the major pending catalysts — most likely the CHIPS definitive agreement or the first-shipment confirmation — is imminent and not yet priced in
• 📅 The December expiry was clearly chosen to capture the full catalyst calendar through the November China restriction deadline
• ⚖️ The position is speculative, not hedging — Vol/OI ≈2.5 means this is fresh directional risk, not portfolio insurance
• 💡 The $30 strike aligns with the $29–$30 gamma level in the chain, suggesting the buyer sees $30 as achievable, not just aspirational

If you own USAR stock:

• ✅ The $25 gamma floor (total GEX 8.30) is your near-term support line — watch it closely
• 📊 Consider that the whale's bet was calls (defined risk), not stock — which limits downside to the premium paid. Holding stock exposes you to the full downside including a potential return to $15–$18 if the thesis breaks
• 🎯 If you've been riding the YTD gain, consider whether your position size is appropriate for a beta-2.41, pre-revenue-scale company

If you're watching from the sidelines:

• 📅 The most important near-term event is the first commercial magnet shipment confirmation — watch for an official press release from USAR IR. That data point either validates or challenges the story
• ⏰ The CHIPS definitive-agreement signing (expected May 2026) is overdue — if it slips into June or beyond, expect the stock to be under pressure
• 🎯 Better entry on options may come after a catalyst (higher IV) or on the next macro dip toward the $22–$24 range (lower stock price, potentially lower extrinsic value)
• ⚠️ If you trade this, size it as pure speculation — position for a loss of 100% of premium as a realistic outcome

Key dates to mark:

• 📅 May 2026 (any day): CHIPS definitive-agreement expected — if it doesn't come by end of May, watch for management commentary
• 📅 Q2 2026 (June–July): First commercial sintered-NdFeB magnet shipment announcement
• 📅 ≈Mid-August 2026: Q2 2026 earnings — first real commercial shipment revenue reported
• 📅 Q3 2026: Serra Verde and TMRC shareholder votes and expected closing
• 📅 ≈November 2026: Q3 2026 earnings; China comprehensive-restriction deadline — the last major catalyst before expiry
• 📅 December 18, 2026: Option expiration

Final verdict: USAR is a genuine rare-earth story with real government backing, a production facility that is now commissioned, and a macro tailwind from China's export-control regime. The whale's $1.4M call buy reflects real conviction in the catalyst stack. But this is a small-cap, pre-revenue-scale, policy-driven name with heavy dilution overhead, a non-binding CHIPS LOI, and a breakeven that demands a 42% stock rally. The defined risk of options (lose only the premium, not more) makes calls a more honest way to express the bull thesis than buying stock at $26 and hoping it goes to $35.

Be eyes-open about the odds. The breakeven is $36.95 at expiry. That is not easy. Size accordingly, know your exit triggers, and never bet more than you are prepared to lose entirely on a story this early-stage. 💪

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. USAR is a small-cap, pre-revenue-scale company with elevated implied volatility — options on names like this can expire worthless even when the underlying thesis is directionally correct. The $1.4M whale trade described here may reflect complex institutional portfolio construction not appropriate or replicable for retail traders. Always do your own research, understand your complete risk before trading, and consider consulting a licensed financial advisor. Options carry a high degree of risk; you can lose the entire premium paid.

---

About USA Rare Earth (USAR): USA Rare Earth, Inc. is a domestic rare-earth and critical-minerals company building a vertically integrated U.S. mine-to-magnet supply chain, targeting defense, EV, robotics, semiconductor, and industrial applications. Market cap ≈$5.8B. NASDAQ: USAR.